The Influence of Aerobic Exercise on Consolidation of Fear Extinction Learning in PTSD
Conditions: PTSD Interventions: Behavioral: Exercise Sponsors: University of Alabama, Tuscaloosa Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
Self-Adaptive Immersive Virtual Reality Serious Game to Enhance Motor Skill Learning and Attention in Older Adults
Conditions: Older Adults; Aging Well; Aging Interventions: Device: Self-adaptive serious game; Device: Non-adaptive serious game Sponsors: Laval University; Universit é Catholique de Louvain Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 21, 2023 Category: Research Source Type: clinical trials
A Proof-of-concept Study to Learn Whether Linvoseltamab Can Prevent Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
Conditions: Monoclonal Gammopathy of Undetermined Significance (MGUS); Smoldering Multiple Myeloma (SMM) Interventions: Drug: Linvoseltamab Sponsors: Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2023 Category: Research Source Type: clinical trials
Learning Theory Patient Education for Anticoagulants
Conditions: Knowledge, Attitudes, Practice Interventions: Behavioral: Anticoagulation Educational Materials; Behavioral: Control Group: Standard of Care Sponsors: University of Utah; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
Conditions: Pulmonary Arterial Hypertension Interventions: Drug: PF-07868489; Drug: Placebo for PF-07868489 Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
A Study to Learn How Different Amounts and Forms of the Study Medicine PF-07899895 Are Tolerated and Act in the Body of Healthy Adults
Conditions: Healthy Participants Interventions: Drug: PF-07899895; Drug: Placebo Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
A Real-World Study to Learn More About the Order of Different Treatments and Their Effects in People With Metastatic Colorectal Cancer Receiving Their Third and Fourth Line of Treatment
Conditions: Metastatic Colorectal Cancer Interventions: Drug: Regorafenib (Stivarga, BAY73-4506) Sponsors: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
A Study to Learn About the Study Medication, Zavegepant, in Healthy Volunteers
Conditions: Biological Availability Interventions: Drug: Zavegepant 100mg non-enteric coated soft gel capsule; Drug: Zavegepant 100mg immediate release tablet; Drug: Zavegepant 2 x 100mg immediate release tablets; Drug: Zavegepant 4 x 25mg enteric coated soft gel capsule Sponsors: Pfizer Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
Rhythm Effect on Dance Learning in Children With and Without Cerebral Palsy.
Conditions: Cerebral Palsy (CP) Interventions: Behavioral: With regular rhythm; Behavioral: Without regular rhythm Sponsors: University Hospital, Toulouse Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
A Study to Learn More About the Safety and the Blood Level of BAY1747846 Given as Injection Into the Vein at Increasing Single Doses in Chinese Healthy Male Participants
Conditions: Contrast Enhancement in Magnetic Resonance Imaging; Healthy Volunteers Interventions: Drug: Gadoquatrane (BAY1747846) 0.03 mmol Gd/kg; Drug: Gadoquatrane (BAY1747846) 0.1 mmol Gd/kg; Drug: Matching placebo Sponsors: Bayer Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials
A Combined School- and Home-Based Sleep Promotion Program
Conditions: Sleep Interventions: Behavioral: Rested& Ready to Learn Sponsors: University of South Carolina; National Institute of General Medical Sciences (NIGMS) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 15, 2023 Category: Research Source Type: clinical trials
Effect of the telemedicine-supported multicomponent exercise therapy in patients with knee osteoarthritis: study protocol for a randomized controlled trial
DiscussionThe aim of the study is to evaluate the effectiveness of multicomponent exercise therapy aimed at enhancing pain self-management for knee osteoarthritis patients in the comfort of their own homes. The intervention incorporate wearable devices equipped with advanced deep learning systems to monitor patients' adherence to the prescribed at-home exercise regimen, as well as to track changes in outcomes before and after the exercise sessions. The findings from this trial have the potential to enhance both the accessibility and quality of care provided to knee osteoarthritis patients, offering valuable insights for fu...
Source: Trials - November 14, 2023 Category: Research Source Type: clinical trials
Development of a Machine Learning Model for Nasopharyngeal Carcinoma Screening Based on Tongue Imaging
Conditions: Nasopharyngeal Carcinoma Interventions: Other: Tongue image Sponsors: Fifth Affiliated Hospital, Sun Yat-Sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 13, 2023 Category: Research Source Type: clinical trials
Learning Early Infant Feeding Cues
Conditions: Responsive Feeding; Infants; Weight Gain Trajectory Interventions: Behavioral: Learning Early Infant Feeding Cues Sponsors: Florida State University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
taVNS for Letter Learning in Dyslexia
Conditions: Dyslexia Interventions: Device: active taVNS; Device: sham taVNS Sponsors: University of Florida Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
